4/A

OWNERSHIP DOCUMENT

Company: Aptevo Therapeutics Inc.
Filed: March 21, 2018
Period of Report: March 19, 2018
Accession Number: 0001019056-18-000465

View Document ↗ View on SEC.gov ↗